The PRESERVE Study: Evaluating Focal Therapy for Prostate Cancer

The PRESERVE Study is a clinical trial evaluating irreversible electroporation (IRE) using the NanoKnife® System for the focal treatment of intermediate-risk, localised prostate cancer. The study focuses on safety, cancer control, and functional outcomes such as urinary and sexual function. 

To learn more about this study, visit: PRESERVE Study - AngioDynamics